How does the need for personalized medicine affect production?
The shift towards personalized medicine, where treatments are tailored to individual patients based on their genetic profile, poses unique production challenges. Personalized therapies, such as targeted therapies and immunotherapies, require customized manufacturing processes. For example, CAR-T cell therapy involves extracting and modifying a patient’s own T cells, which is a time-consuming and complex process. Scaling up these therapies while maintaining personalization and quality is a significant production hurdle.
